https://mcc950inhibitor.com/pr....oteomic-screening-pr
The combined drug and control groups exhibited no discernible difference in peak AST serum levels (geometric mean: 12629 U/L [95% CI, 9463-16854 U/L] vs 14512 U/L [95% CI, 10874-19367 U/L]; geometric mean ratio, 0.87 [95% CI, 0.58-1.31]; P=0.49). (Multiply by 0.00167 to convert AST to kat/L.) In terms of secondary endpoints, the groups displayed no appreciable differences. Despite a combined drug therapy applied to the post-cold stor